Qilian International Holding Group Limited (QLI)

Etorro trading 970x250

About Qilian International Holding Group Limited

Qilian International Holding Group Limited engages in the research, development, and production of active pharmaceutical ingredients (APIs) and traditional Chinese medicine derivative (TCMD) products in China. The company offers licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions. It also provides Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline APIs for pharmaceutical companies to manufacture medications. In addition, the company offers TCMD products, such as Ahan antibacterial paste to treat refractory chronic skin diseases; heparin products, including heparin sodium preparations for pharmaceutical companies to produce medications for cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and sausage casings comprising Zhu Xiaochang sausage casings, which are natural food products for culinary application. Further, it provides Xiongguan organic fertilizers to improve crop yield and soil’s chemical properties, and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers to increased plant growth. The company was incorporated in 2019 and is based in Jiuquan, the People’s Republic of China. Address: Jiuquan Eco & Tech Dev Zn, Jiuquan, China, 735000

Qilian International Holding Group Limited News and around…

Latest news about Qilian International Holding Group Limited (QLI) common stock and company :

Qilian International Holding Group Limited Announces Inclusion of Gan Di Xin® and Qilian Shan® Oxytetracycline into List for Development of Leading Enterprises with Large Varieties and Brands of Pharmaceuticals of Gansu Province
23 Nov, 2021 Yahoo! Finance

Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company"), a China-based pharmaceutical and chemical products manufacturer, today announced that Gan Di Xin® and Qilian Shan® Oxytetracycline, products of the Company's subsidiary, Gansu Qilianshan Pharmaceutical Co., Ltd. ("Gansu QLS"), have been included in the List for Development of Leading Enterprises with Large Varieties and Brands of Pharmaceuticals of Gansu Province (the "List"). The List selects key medicines and medical dev

Qilian International Holding Group Limited Announces Initiation of Development of New Drug for Gastric Cancer Prevention
15 Nov, 2021 Yahoo! Finance

Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company"), a China-based pharmaceutical and chemical products manufacturer, announced that the Company recently started, through its subsidiary Gansu Qilianshan Pharmaceutical Co., Ltd. ("Gansu QLS"), developing a new drug, Vitacoenzyme (the "Drug"), that aims to prevent gastric cancer. Currently, Gansu QLS is in the process of selecting and cultivating fungal strain. The Drug is expected to be on the market within three years.

Qilian International Holding Group Limited Donates Pharmaceutical Products Gan Di Xin® Worth RMB500,000 and Other Materials to Help Fight Local COVID-19 Epidemic
01 Nov, 2021 Yahoo! Finance

Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company"), a China-based pharmaceutical and chemical products manufacturer, announced that recently, through its subsidiary Gansu Qilianshan Pharmaceutical Co., Ltd. ("Gansu QLS"), the Company donated Gan Di Xin®, its self-developed antitussive and expectorant medicine, and 75% alcohol disinfectant, with an aggregate value of more than RMB500,000 to the government of Suzhou District, Jiuquan City to help control the spread of local C

Qilian International Holding Group Limited Completes Phase One of Its Expansion of New Organic Fertilizer Production Facility and Puts It into Production
26 Oct, 2021 Yahoo! Finance

Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company"), a China-based pharmaceutical and chemical products manufacturer, today announced that the Company has completed phase one of the expansion of its new organic fertilizer production facility. As a result, the Company's annual production capacity of organic fertilizers has increased to 30,000 tons. After the Expansion is fully complete, the Company's annual production capacity of organic fertilizers is expected to reach 50,00

Is Qilian International Holding Group Limited's (NASDAQ:QLI) Recent Price Movement Underpinned By Its Weak Fundamentals?
25 Oct, 2021 Yahoo! Finance

It is hard to get excited after looking at Qilian International Holding Group's (NASDAQ:QLI) recent performance, when...

Qilian International Holding Group Limited Received Approval for Oxytetracycline API Export to Egypt
13 Oct, 2021 Yahoo! Finance

Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company"), a China-based pharmaceutical and chemical products manufacturer, announced that on September 14, 2021, through its subsidiary Gansu Qilianshan Pharmaceutical Co., Ltd. (the "Gansu QLS"), it has received Certificate of a Pharmaceutical Product (the "Export Certificate") from Gansu Province Drug Administration, which approves the export of its Qilian Shan® Oxytetracycline APIs (Active Pharmaceutical Ingredients) (the "API")

Qilian International Holding Group Limited Reports Financial Results for the First Six Months of Fiscal Year 2021
16 Sep, 2021 FinancialContent
12 Health Care Stocks Moving In Monday's Pre-Market Session
23 Aug, 2021 FinancialContent

Gainers Vivos Therapeutics (NASDAQ:VVOS) stock increased by 64.84% to $6.33 during Monday's pre-market session. The ...

Qilian International Holding Group Limited Signs Agreement with District Government, Settling the Project in Local High-tech Zone
05 Aug, 2021 FinancialContent
A Look At The Intrinsic Value Of Qilian International Holding Group Limited (NASDAQ:QLI)
27 Jul, 2021 Yahoo! Finance

Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Qilian International...

Qilian International Holding Group Limited Enters into Investment Agreement for Pig By-product Processing Project in Chongqing
09 Jul, 2021 FinancialContent
Stocks That Hit 52-Week Lows On Tuesday
06 Jul, 2021 FinancialContent

Tuesday morning, 51 companies reached new 52-week lows. Noteworthy Highlights: China Life Insurance Co ...

What You Need To Know About Qilian International Holding Group Limited's (NASDAQ:QLI) Investor Composition
11 Jun, 2021 Yahoo! Finance

The big shareholder groups in Qilian International Holding Group Limited ( NASDAQ:QLI ) have power over the company...

Qilian International Holding Group Limited Enters into Exclusive Agency Agreement with Kangzhiyuan to Boost Sales of Gan Di Xin®
05 May, 2021 FinancialContent
Qilian International Holding Group Limited Announces Inclusion of 16 Products into China's National Reimbursement Drugs List
13 Apr, 2021 FinancialContent
Qilian International Holding Group Limited (NASDAQ:QLI) Not Lagging Market On Growth Or Pricing
12 Apr, 2021 Yahoo! Finance

Qilian International Holding Group Limited's ( NASDAQ:QLI ) price-to-earnings (or "P/E") ratio of 27.3x might make it...

Penny Stocks To Watch For April 2021 If You Like Biotech
07 Apr, 2021 FinancialContent
32 Stocks Moving in Monday's Pre-Market Session
29 Mar, 2021 FinancialContent

Gainers Universe Pharmaceuticals INC (NASDAQ: UPC) rose 237.6% to $13.74 in pre-market trading. Universe Pharmaceuticals, last ...

Qilian International Holding Group Limited CEO Receives Outstanding Entrepreneur Award
18 Feb, 2021 FinancialContent
Qilian International Holding Group Limited Reports Fiscal Year 2020 Financial Results
11 Feb, 2021 FinancialContent
Qilian International Holding Group Limited to Triple Organic Fertilizer Production Capacity by March 2021
08 Feb, 2021 FinancialContent
Univest Securities, LLC. Announces Closing of IPO for its Client Qilian International Holding Group Limited (Nasdaq: QLI)
19 Jan, 2021 Yahoo! Finance

New York, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, is a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of the initial public offering (“IPO”) for its client Qilian International Holding Group Limited (the “Company”), marking the first IPO in 2021 to which Univest acts as the sole book-running manager. A total of 5,750,000 ordinary shares of the Company, including 750,000 ordinary shares pursuant to Univest’s full exervise of the over-allotment option, are offered at a public offering price of $5.00 per share, raising aggregate gross proceeds of $28,750,000, before deducting underwriting discounts and other related expenses. The ordinary shares began trading on the Nasdaq Global Market on January 12, 2021 under the ticker symbol “QLI”. The Offering was conducted on a firm commitment basis. Univest Securities, LLC acted as the representative of the underwriters and the sole book-running manager for the Offering. Loop Capital Markets and Alexander Capital L.P. acted as co-managers for the Offering. Hunter Taubman Fischer & Li LLC acted as counsel to the Company, and Ortoli Rosenstadt LLP acted as counsel to Univest Securities, LLC in connection with the Offering. A registration statement on Form F-1 relating to the Offering was filed with the Securities and Exchange Commission (“SEC”) (File Number: 333-234460) and was declared effective by the SEC on December 30, 2020. This Offering was made only by means of a prospectus, forming a part of the registration statement. Copies of the final prospectus relating to the Offering may be obtained from Univest Securities, LLC, by email at IBAssistDesk@univest.us or standard mail to Univest Securities, LLC, Attn: 375 Park Avenue, 15th Floor, New York, NY 10152. In addition, a copy of the prospectus relating to the Offering may be obtained via the SEC's website at www.sec.gov. Before you invest, you should read the prospectus and other documents the Company has filed or will file with the SEC for more complete information about the Company and the Offering. This press release does not constitute an offer to sell, or the solicitation of an offer to buy any of the Company’s securities, nor shall such securities be offered or sold in the United States absent registration or an applicable exemption from registration, nor shall there be any offer, solicitation or sale of any of the Company’s securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. About Univest Securities, LLC Registered with FINRA since 1994, Univest Securities, LLC provides a wide variety of financial services to its institutional and retail clients globally including brokerage and execution services, sales and trading, market making, investment banking and advisory, wealth management. It strives to provide clients with value-add service and focuses on building long-term relationship with its clients. For more information, please visit: www.univest.us. About Qilian International Holding Group Limited Qilian International Holding Group Limited, headquartered in Gansu, China, is a pharmaceutical and chemical products manufacturer in China. It focuses on the development, manufacture, marketing and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives product, heparin product, sausage casings, and fertilizers. The Company’s products are sold in more than 20 provinces in China. For more information, visit the company’s website at http://ir.qlsyy.net/. Forward-Looking Statements This announcement contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact in this announcement are forward-looking statements, including but not limited to, the Company's proposed Offering. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy and financial needs, including the expectation that the Offering will be successfully completed. Investors can identify these forward-looking statements by words or phrases such as "may," "will," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "is/are likely to" or other similar expressions. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and in its other filings with the SEC. For more information, please contact: Univest Securities, LLC.Edric GuoExecutive Director of Investment Banking375 Park Avenue #1502New York, NY 10152Phone: (212) 343-8888Email: info@univest.us

Qilian International Holding Group Limited Announces Full Exercise of Underwriters’ Over-Allotment Option
19 Jan, 2021 FinancialContent
70 Biggest Movers From Yesterday
15 Jan, 2021 FinancialContent

Gainers Poshmark, Inc. (NASDAQ: POSH) shares climbed 141.7% to close at $101.50 on Thursday as the company priced its IPO at $42 ...

Qilian International Holding Group Limited Announces Closing of Initial Public Offering
15 Jan, 2021 FinancialContent
12 Health Care Stocks Moving In Thursday's Intraday Session
14 Jan, 2021 FinancialContent

Gainers Lexicon Pharmaceuticals (NASDAQ:LXRX) stock moved upwards by 78.57% to $7.0 during Thursday's regular ...

52 Stocks Moving In Thursday's Mid-Day Session
14 Jan, 2021 FinancialContent

Gainers Datasea Inc. (NASDAQ: DTSS) shares jumped 82% to $4.33 after the company reported establishment of a new company to ...

80 Biggest Movers From Yesterday
14 Jan, 2021 FinancialContent

Gainers Live Ventures Incorporated (NASDAQ: LIVE) shares jumped 90.4% to close at $23.90 on Wednesday after the company swung to a ...

12 Health Care Stocks Moving In Wednesday's Intraday Session
13 Jan, 2021 FinancialContent

Gainers Acorda Therapeutics (NASDAQ:ACOR) stock moved upwards by 33.02% to $5.64 during Wednesday's regular session. ...

61 Stocks Moving In Wednesday's Mid-Day Session
13 Jan, 2021 FinancialContent

Gainers Live Ventures Incorporated (NASDAQ: LIVE) shares climbed 101.4% to $25.28 after the company swung to a profit in the ...

Qilian International Holding Group Limited (QLI) is a NASDAQ Common Stock listed in , ,

970x250